An Intervention Study To Improve Human PapillomaVirus ( HPV) Immunization in Haitian and African American Girls

Sponsor
Boston Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT01254669
Collaborator
(none)
200
1
2
37.9
5.3

Study Details

Study Description

Brief Summary

In the United States, Black women are more likely to die of cervical cancer than White women. In developing countries and globally, Haitian immigrant women are more likely to die of cervical cancer than any other women in the world. Studies have shown a disparity in parental acceptance of the HPV vaccine with parents of Black adolescent girls being less likely to accept and comply with HPV immunization schedules than Whites. The objective of this study is to increase HPV immunization rates in Haitian and African American adolescent girls. The investigator's hypothesis is that a validated behavior change mechanism, brief-negotiating interviewing (BNI), will effectively increase the proportion of mothers who give consent for their daughters' HPV vaccine, which will ultimately lead to higher vaccination rates, and increase knowledge of HPV infection and the vaccine in Haitian immigrant and African American mothers.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: BNI-brief Negotiated Interview
N/A

Detailed Description

In the U.S., Black women have higher rates of cervical cancer than White women. Women in Haiti and Haitian immigrant women have among the highest rates of cervical cancer in the world. The recent introduction of the HPV vaccine provides an opportunity to reduce the disparity in cervical cancer rates between White and Black non-White (Haitians and US born African-Americans (AA)). Unfortunately, females ages 11-14 have low rates, 25%, of HPV vaccination. For the vaccine to be effective it must be given prior to the onset of sexual activity. Parents are a central audience for interventions to promote HPV vaccine uptake in children < 18 since parents have to consent.

Hypothesis: The objective of this study is to increase HPV immunization rates in Haitian and African American adolescent girls. My hypothesis is that a validated behavior change mechanism, brief-negotiating interviewing (BNI), will effectively increase the proportion of mothers who give consent for their daughters' HPV vaccine, which will ultimately lead to higher vaccination rates, and increase knowledge of HPV infection and the vaccine in Haitian immigrant and African American mothers.

Specific Aim 1a: Develop a script that will use BNI to address low-income Haitian immigrant and African American mothers' concern about HPV immunization

Specific Aim 1b: Teach community health workers to use BNI to enhance HPV acceptability Specific aim 2: Conduct a pilot, randomized clinical trial to determine feasibility effectiveness of BNI, and to obtain empirical estimates of study parameters to assess logistical aspects of a larger Randomized Clinical Trial (RCT). This will include assessing recruitment and retention of subjects, intervention delivery, and effect size.

Study design: The primary study design will be a RCT which will follow the CONSORT requirements for data reporting and analysis. One-hundred immigrant Haitian mothers bringing their adolescent daughters (age range 11 to 15) to clinic for routine care will be randomized to BNI (n=80) or to standard care (N=80) information about HPV vaccine). The primary outcome will be receipt of the first HPV vaccination in the adolescent within 1 month of randomization. The secondary outcome will be maternal knowledge about HPV vaccine. This study will provide key estimates so that we can conduct a fully-powered RCT, which will include completion of the primary HPV series (3 vaccinations) as the primary outcome.

Study Design

Study Type:
Interventional
Actual Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
A Randomized Clinical Trial To Improve HPV Immunization in Haitian and African American Girls
Study Start Date :
Jan 1, 2011
Actual Primary Completion Date :
Oct 1, 2013
Actual Study Completion Date :
Mar 1, 2014

Arms and Interventions

Arm Intervention/Treatment
No Intervention: control, standard of care

Mothers assigned to the Control Group received the low-literacy, standard-practice, HPV-vaccine information sheet

Experimental: BNI-brief Negotiated Interview

The BNI intervention addressed mothers' beliefs, values, and concerns about HPV prevention and takes their priorities for health and well-being into account.

Behavioral: BNI-brief Negotiated Interview
use of a cognitive behavioral intervention to improve uptake of HPV vaccine
Other Names:
  • brief intervention to improve HPV vaccine in girls
  • Outcome Measures

    Primary Outcome Measures

    1. The Receipt of the First HPV Vaccination [within 1 month of randomization]

      Receipt of the first HPV vaccination among adolescent daughters of the participants

    Secondary Outcome Measures

    1. The Secondary Outcome Will be Maternal Knowledge About HPV Vaccine. [1 hour after intervention]

      post-educational intervention assessment of HPV knowledge ranges from 0 (minimal knowledge) to 12 (maximal knowledge)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    11 Years to 15 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • 11-15 HPV vaccine eligible adolescent girls
    Exclusion Criteria:
    • Prior receipt of the HPV vaccine

    • pregnant

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Boston Medical Center Boston Massachusetts United States 02118

    Sponsors and Collaborators

    • Boston Medical Center

    Investigators

    • Principal Investigator: natalie joseph, MD, MPH, Boston Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Natalie Pierre-Joseph, Assistant Professor, Boston Medical Center
    ClinicalTrials.gov Identifier:
    NCT01254669
    Other Study ID Numbers:
    • H26306
    First Posted:
    Dec 6, 2010
    Last Update Posted:
    May 19, 2017
    Last Verified:
    Apr 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Natalie Pierre-Joseph, Assistant Professor, Boston Medical Center
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details We recruited 100 English- and 100 Haitian Creole-speaking mothers of adolescent girls between April 2011 and September 2013 at the medical clinic ( pediatrics and adolescent clinic). Of 1,703 mothers approached during the study period,1,201 were ineligible. Of the 502 eligible, 302 declined and 200 (40%) were recruited &consented to pilot trial.
    Pre-assignment Detail Following participant enrollment, but prior to group assignment, no significant event occurred. However, in our study after being randomized, participants provided demographic data. During data collection, one participants was excluded/self-withdrew from the trial for fear that demographic data may affect her immigration status/not documented.
    Arm/Group Title Standard of Care Brief Negotiated Inteview (BNI) Intervention
    Arm/Group Description A clinical Pilot trials of a Brief Negotiated Intervention (a brief modified version of Motivational interview using a client-centered style) with mothers to improve Human Papilloma Virus (HPV) vaccination in Haitian and African-American adolescent daughters/girls compare to standard of care. Mothers assigned to the Control Group received the low-literacy, standard-practice, HPV vaccine information sheet usually given to all patients prior to vaccination. Control mothers met once with the research assistant to collect demographic characteristics, HPV knowledge, and vaccine status of the daughter on the day of visit. No Brief Negotiated Intervention (BNI) counseling was provided. A clinical Pilot trials of a Brief Negotiated Intervention (a brief modified version of Motivational interview using a client-centered style) with mothers to improve HPV vaccination in Haitian and African-American adolescent daughters/girls compare to standard of care. One hundred mothers received intervention (n=50 Haitian, 50 African-American). Four Haitian mothers did not receive intervention because (i) One was called to see the clinical provider during the intervention and did not return (n=1), and (ii) time constraints (n=2) and one dropped out for fear information from study will affect her immigration status
    Period Title: Overall Study
    STARTED 100 100
    COMPLETED 97 96
    NOT COMPLETED 3 4

    Baseline Characteristics

    Arm/Group Title Standard of Care BNI/Intervention Total
    Arm/Group Description A clinical Pilot trials of a Brief Negotiated Intervention (a brief modified version of Motivational interview using a client-centered style) with mothers to improve HPV vaccination in Haitian and African-American adolescent daughters/girls compare to standard of care. Of the 100 women in the Control Group (n=50 Haitian, 50 African-American), three African-American mothers did not complete Control Group activities because they did not complete the survey. Reasons for initial dropout/decline to participate included being too busy, not interested, time constraints, and daughter not sexually active upon hearing study has to do with HPV vaccine. One hundred mothers received intervention (n=50 Haitian, 50 African-American). Four Haitian mothers did not receive intervention because (i) One was called to see the clinical provider during the intervention and did not return (n=1), and (ii) time constraints (n=2), one for immigration status . Total of all reporting groups
    Overall Participants 100 100 200
    Age (years) [Mean (Standard Deviation) ]
    age
    41
    (7)
    40
    (9)
    41
    (8)
    Age (Count of Participants)
    <=18 years
    0
    0%
    0
    0%
    0
    0%
    Between 18 and 65 years
    100
    100%
    100
    100%
    200
    100%
    >=65 years
    0
    0%
    0
    0%
    0
    0%
    Sex: Female, Male (Count of Participants)
    Female
    100
    100%
    100
    100%
    200
    100%
    Male
    0
    0%
    0
    0%
    0
    0%
    Race (NIH/OMB) (Count of Participants)
    American Indian or Alaska Native
    0
    0%
    0
    0%
    0
    0%
    Asian
    0
    0%
    0
    0%
    0
    0%
    Native Hawaiian or Other Pacific Islander
    0
    0%
    0
    0%
    0
    0%
    Black or African American
    100
    100%
    100
    100%
    200
    100%
    White
    0
    0%
    0
    0%
    0
    0%
    More than one race
    0
    0%
    0
    0%
    0
    0%
    Unknown or Not Reported
    0
    0%
    0
    0%
    0
    0%
    Ethnicity (NIH/OMB) (Count of Participants)
    Hispanic or Latino
    0
    0%
    0
    0%
    0
    0%
    Not Hispanic or Latino
    100
    100%
    100
    100%
    200
    100%
    Unknown or Not Reported
    0
    0%
    0
    0%
    0
    0%
    Region of Enrollment (participants) [Number]
    United States
    100
    100%
    100
    100%
    200
    100%
    knowledge of HPV vaccine (units on a scale) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [units on a scale]
    5
    (4)
    6
    (4)
    5
    (4)

    Outcome Measures

    1. Primary Outcome
    Title The Receipt of the First HPV Vaccination
    Description Receipt of the first HPV vaccination among adolescent daughters of the participants
    Time Frame within 1 month of randomization

    Outcome Measure Data

    Analysis Population Description
    The number of participants for analysis was determined based on number of participants enrolled and who answered questions of interest.
    Arm/Group Title Standard of Care BNI/Intervention
    Arm/Group Description A clinical Pilot trials of a Brief Negotiated Intervention (a brief modified version of Motivational interview using a client-centered style) with mothers to improve HPV vaccination in Haitian and African-American adolescent daughters/girls compare to standard of care. Of the 100 women in the Control Group (n=50 Haitian, 50 African-American), received the standard of care handout given to patients on the vaccine they will be getting that day. three African-American mothers did not complete Control Group activities because they did not complete the survey. Reasons for initial dropout/decline to participate included being too busy, not interested, time constraints, and daughter not sexually active upon hearing study has to do with HPV vaccine. Intervention was administered to 100 African-American and Haitian mothers over 10-20 minutes prior to seeing the health provider if the daughter had never received the HPV vaccine, or after seeing the health provider if the daughter did not received the vaccine during the visit.
    Measure Participants 97 96
    Number [percentage of participants]
    51
    51%
    56
    56%
    2. Secondary Outcome
    Title The Secondary Outcome Will be Maternal Knowledge About HPV Vaccine.
    Description post-educational intervention assessment of HPV knowledge ranges from 0 (minimal knowledge) to 12 (maximal knowledge)
    Time Frame 1 hour after intervention

    Outcome Measure Data

    Analysis Population Description
    The number of participants for analysis was determined based on the total enrolled and who responded to knowledge questions
    Arm/Group Title BNI Post-educational Intervention Group Control Group
    Arm/Group Description A clinical Pilot trials of a Brief Negotiated Intervention (a brief modified version of Motivational interview using a client-centered style) with mothers to improve HPV vaccination in Haitian and African-American adolescent daughters/girls compare to standard of care. Post-educational interventional assessment of HPV knowledge ranges from 0(minimal knowledge) to 12 (maximal knowledge) Did not receive any BNI intervention on the pre and post measure
    Measure Participants 99 96
    Mean (Standard Deviation) [units on a scale]
    10
    (2)
    5
    (2)

    Adverse Events

    Time Frame 1 year- no adverse event over
    Adverse Event Reporting Description no adverse event
    Arm/Group Title Standard of Care BNI/Intervention
    Arm/Group Description A clinical Pilot trials of a Brief Negotiated Intervention (a brief modified version of Motivational interview using a client-centered style) with mothers to improve HPV vaccination in Haitian and African-American adolescent daughters/girls compare to standard of care. Of the 100 women in the Control Group (n=50 Haitian, 50 African-American), three African-American mothers did not complete Control Group activities because they did not complete the survey. Reasons for initial dropout/decline to participate included being too busy, not interested, time constraints, and daughter not sexually active upon hearing study has to do with HPV vaccine. One hundred mothers received intervention (n=50 Haitian, 50 African-American). . Four Haitian mothers did not receive intervention because (i) One was called to see the clinical provider during the intervention and did not return (n=1), and (ii) time constraints (n=2), one due to fear of information affecting immigration status.
    All Cause Mortality
    Standard of Care BNI/Intervention
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total / (NaN) / (NaN)
    Serious Adverse Events
    Standard of Care BNI/Intervention
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/100 (0%) 0/100 (0%)
    Other (Not Including Serious) Adverse Events
    Standard of Care BNI/Intervention
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/100 (0%) 0/100 (0%)

    Limitations/Caveats

    Limitations:small sample,Enrolling only mothers, of daughters who are African-American and Haitians lead to longer recruitment time/non-generalizable data. Future studies should include heterogeneous ethnicities,fathers, sons, and any legal guardian.

    More Information

    Certain Agreements

    All Principal Investigators ARE employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Dr. Natalie Joseph
    Organization Boston Medical Center
    Phone 1-617-414-5202
    Email napierre@bu.edu
    Responsible Party:
    Natalie Pierre-Joseph, Assistant Professor, Boston Medical Center
    ClinicalTrials.gov Identifier:
    NCT01254669
    Other Study ID Numbers:
    • H26306
    First Posted:
    Dec 6, 2010
    Last Update Posted:
    May 19, 2017
    Last Verified:
    Apr 1, 2017